S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
T   39.50 (+1.39%)
BAC   32.92 (+0.67%)
DIS   144.67 (-1.69%)
S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
T   39.50 (+1.39%)
BAC   32.92 (+0.67%)
DIS   144.67 (-1.69%)
S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
T   39.50 (+1.39%)
BAC   32.92 (+0.67%)
DIS   144.67 (-1.69%)
S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
T   39.50 (+1.39%)
BAC   32.92 (+0.67%)
DIS   144.67 (-1.69%)
Log in

Dicerna Pharmaceuticals SEC Filings & 10K Form (NASDAQ:DRNA)

$19.31
-0.86 (-4.26 %)
(As of 11/15/2019 04:00 PM ET)
Today's Range
$19.25
Now: $19.31
$20.42
50-Day Range
$13.68
MA: $15.93
$20.38
52-Week Range
$9.31
Now: $19.31
$20.89
Volume96,218 shs
Average Volume597,185 shs
Market Capitalization$1.32 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.29

SEC Filings

Dicerna Pharmaceuticals (NASDAQ:DRNA) SEC Filings

DateFilerForm TypeView
11/07/2019
3:44 PM
Dicerna Pharmaceuticals (Filer)
Form S-3ASR
11/07/2019
3:13 PM
Dicerna Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2019
3:11 PM
Dicerna Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2019
6:03 PM
Dicerna Pharmaceuticals (Issuer)
GREEN JOHN B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2019
6:00 PM
Dicerna Pharmaceuticals (Issuer)
Weissman James B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2019
5:30 AM
Dicerna Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2019
6:30 PM
Dicerna Pharmaceuticals (Issuer)
Weissman James B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2019
3:39 PM
Dicerna Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2019
3:38 PM
Dicerna Pharmaceuticals (Issuer)
GRAY PATRICK M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2019
3:22 PM
Dicerna Pharmaceuticals (Issuer)
GRAY PATRICK M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/19/2019
3:08 PM
Dicerna Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2019
7:31 PM
Dicerna Pharmaceuticals (Issuer)
Weissman James B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
4:09 PM
Dicerna Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/08/2019
3:25 PM
Dicerna Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/01/2019
4:44 PM
Ciappenelli Robert D. (Reporting)
Dicerna Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
3:04 PM
Dicerna Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2019
7:03 PM
Dicerna Pharmaceuticals (Issuer)
KOZIN MARC D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
7:02 PM
Dicerna Pharmaceuticals (Issuer)
Koppel Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
7:01 PM
Dicerna Pharmaceuticals (Issuer)
Protopapas Anna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
7:01 PM
Dicerna Pharmaceuticals (Issuer)
LANGER DENNIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
7:01 PM
Dicerna Pharmaceuticals (Issuer)
HOFFMAN STEPHEN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
7:00 PM
BUCHI J KEVIN (Reporting)
Dicerna Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
7:00 PM
Dicerna Pharmaceuticals (Issuer)
Freed Martin I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
7:00 PM
Dicerna Pharmaceuticals (Issuer)
Kolchinsky Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
7:00 PM
Dicerna Pharmaceuticals (Issuer)
Smith Cynthia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
7:00 PM
Ciappenelli Robert D. (Reporting)
Dicerna Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/10/2019
2:47 PM
Dicerna Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/04/2019
7:00 PM
Dicerna Pharmaceuticals (Issuer)
Weissman James B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2019
7:00 PM
BUCHI J KEVIN (Reporting)
Dicerna Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2019
9:48 AM
Dicerna Pharmaceuticals (Filer)
Form CT ORDER
03/13/2019
4:31 PM
Dicerna Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2019
10:38 AM
Dicerna Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
Form SC 13G/A
02/14/2019
8:25 AM
Dicerna Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
02/13/2019
10:50 AM
Dicerna Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/08/2019
8:00 PM
Dicerna Pharmaceuticals (Issuer)
FAMBROUGH DOUGLAS (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/25/2019
8:10 PM
Dicerna Pharmaceuticals (Issuer)
Protopapas Anna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
8:10 PM
Dicerna Pharmaceuticals (Issuer)
KOZIN MARC D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
8:00 PM
Dicerna Pharmaceuticals (Issuer)
KOZIN MARC D (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/25/2019
8:00 PM
Dicerna Pharmaceuticals (Issuer)
Protopapas Anna (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/25/2019
4:29 PM
Dicerna Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2019
3:30 PM
Dicerna Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2019
8:09 PM
Dicerna Pharmaceuticals (Issuer)
GREEN JOHN B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
8:01 PM
Dicerna Pharmaceuticals (Issuer)
Weissman James B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
8:01 PM
Brown Bob D (Reporting)
Dicerna Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
8:01 PM
Dicerna Pharmaceuticals (Issuer)
FAMBROUGH DOUGLAS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
8:01 PM
Dicerna Pharmaceuticals (Issuer)
ROSSKAMP RALF (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
5:07 AM
Dicerna Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2018
2:42 PM
Dicerna Pharmaceuticals (Subject)
LILLY ELI & CO (Filed by)
Form SC 13D
11/07/2018
4:13 PM
Dicerna Pharmaceuticals (Filer)
Form 10-Q/A
11/06/2018
5:21 PM
Dicerna Pharmaceuticals (Issuer)
Kolchinsky Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2018
3:16 PM
Dicerna Pharmaceuticals (Issuer)
Halak Brian K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2018
3:43 PM
Dicerna Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2018
3:10 PM
Dicerna Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2018
9:30 AM
Dicerna Pharmaceuticals (Subject)
Domain Partners VIII, L.P. (Filed by)
Form SC 13D/A
11/05/2018
9:05 AM
Dicerna Pharmaceuticals (Issuer)
Halak Brian K (Reporting)
Form 4/A
11/01/2018
6:52 PM
Dicerna Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13D/A
11/01/2018
6:44 PM
Dicerna Pharmaceuticals (Issuer)
Kolchinsky Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2018
5:08 PM
Dicerna Pharmaceuticals (Issuer)
Halak Brian K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2018
5:17 AM
Dicerna Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2018
5:30 AM
Dicerna Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2018
4:28 PM
Dicerna Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2018
5:09 AM
Dicerna Pharmaceuticals (Filer)
Form 424B5
09/06/2018
1:21 PM
Dicerna Pharmaceuticals (Issuer)
Weissman James B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2018
5:06 AM
Dicerna Pharmaceuticals (Filer)
Form 424B5
09/05/2018
5:22 AM
Dicerna Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2018
8:00 PM
Dicerna Pharmaceuticals (Issuer)
Weissman James B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2018
8:00 PM
Dicerna Pharmaceuticals (Issuer)
LANGER DENNIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2018
3:03 PM
Dicerna Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2018
8:02 PM
BUCHI J KEVIN (Reporting)
Dicerna Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2018
8:01 PM
Dicerna Pharmaceuticals (Issuer)
Smith Cynthia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2018
8:01 PM
BUCHI J KEVIN (Reporting)
Dicerna Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2018
8:00 PM
Dicerna Pharmaceuticals (Issuer)
Smith Cynthia (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/08/2018
3:14 PM
Dicerna Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2018
8:15 PM
Dicerna Pharmaceuticals (Issuer)
Wise Bart W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2018
8:00 PM
Dicerna Pharmaceuticals (Issuer)
Wise Bart W (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/25/2018
8:02 PM
Dicerna Pharmaceuticals (Issuer)
MADDEN DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2018
8:00 PM
Dicerna Pharmaceuticals (Issuer)
HOFFMAN STEPHEN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2018
8:00 PM
Dicerna Pharmaceuticals (Issuer)
Kolchinsky Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2018
8:00 PM
Dicerna Pharmaceuticals (Issuer)
LANGER DENNIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2018
8:00 PM
Dicerna Pharmaceuticals (Issuer)
Freed Martin I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2018
3:53 PM
Dicerna Pharmaceuticals (Issuer)
Halak Brian K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2018
3:19 PM
Dicerna Pharmaceuticals (Issuer)
Koppel Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2018
4:15 PM
Dicerna Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2018
4:08 PM
BRIDGER MANAGEMENT, LLC (Filed by)
Dicerna Pharmaceuticals (Subject)
Form SC 13G
06/11/2018
3:12 PM
Dicerna Pharmaceuticals (Issuer)
Halak Brian K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
11:15 PM
Dicerna Pharmaceuticals (Filer)
Form EFFECT
05/14/2018
3:10 PM
Dicerna Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2018
3:06 PM
Dicerna Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/11/2018
8:00 PM
Dicerna Pharmaceuticals (Issuer)
Weissman James B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2018
8:00 PM
Brown Bob D (Reporting)
Dicerna Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2018
11:15 PM
Dicerna Pharmaceuticals (Filer)
Form EFFECT
05/04/2018
4:30 PM
Dicerna Pharmaceuticals (Filer)
Form S-3/A
04/26/2018
3:47 PM
Dicerna Pharmaceuticals (Filer)
Form DEFA14A
04/26/2018
3:43 PM
Dicerna Pharmaceuticals (Filer)
Form DEF 14A
04/26/2018
3:38 PM
Dicerna Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2018
8:30 PM
Dicerna Pharmaceuticals (Issuer)
Weissman James B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2018
6:58 AM
Dicerna Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2018
3:24 PM
Dicerna Pharmaceuticals (Issuer)
Kolchinsky Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2018
3:20 PM
Dicerna Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13D/A
03/21/2018
8:30 PM
Dicerna Pharmaceuticals (Issuer)
Weissman James B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 11/15/2019 by MarketBeat.com Staff

Featured Article: What is a Call Option?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel